GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 133 filers reported holding GOSSAMER BIO INC in Q2 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,686 | -41.9% | 6,100 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $13,237 | -99.9% | 6,100 | -99.5% | 0.00% | -99.9% |
| Q3 2022 | $13,830,000 | +23.8% | 1,154,407 | -13.5% | 2.76% | +35.2% |
| Q2 2022 | $11,173,000 | +28.5% | 1,334,887 | +33.2% | 2.04% | +78.3% |
| Q1 2022 | $8,695,000 | -43.8% | 1,001,815 | -26.7% | 1.14% | -50.4% |
| Q4 2021 | $15,461,000 | -20.0% | 1,366,933 | -11.1% | 2.30% | +69.2% |
| Q3 2021 | $19,325,000 | +127.0% | 1,537,333 | +46.6% | 1.36% | +97.8% |
| Q2 2021 | $8,513,000 | -31.7% | 1,048,383 | -22.2% | 0.69% | +64.2% |
| Q1 2021 | $12,472,000 | -9.8% | 1,348,383 | -5.7% | 0.42% | -31.3% |
| Q4 2020 | $13,826,000 | +67.8% | 1,429,683 | +115.4% | 0.61% | +2.3% |
| Q3 2020 | $8,238,000 | -10.0% | 663,794 | -5.7% | 0.60% | -18.1% |
| Q2 2020 | $9,152,000 | -24.1% | 703,999 | -8.7% | 0.73% | -62.7% |
| Q4 2019 | $12,052,000 | – | 771,100 | – | 1.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,164,835 | $27,471,000 | 5.62% |
| Kynam Capital Management, LP | 1,832,704 | $15,908,000 | 5.16% |
| Octagon Capital Advisors LP | 2,563,138 | $22,248,000 | 4.81% |
| Ally Bridge Group (NY) LLC | 450,000 | $3,906,000 | 2.90% |
| HHLR ADVISORS, LTD. | 7,420,974 | $64,414,000 | 1.34% |
| Palo Alto Investors LP | 1,756,757 | $15,249,000 | 1.18% |
| Boxer Capital, LLC | 2,462,358 | $21,373,000 | 1.10% |
| Ikarian Capital, LLC | 775,315 | $6,730,000 | 0.88% |
| Artal Group S.A. | 2,358,968 | $20,476,000 | 0.86% |
| Birchview Capital, LP | 129,088 | $1,120,000 | 0.81% |